Related Experiment Video
Updated: Jul 15, 2026
09:31
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
The new EANM paediatric dosage card
M Lassmann1, L Biassoni2, M Monsieurs3
1Klinik und Poliklinik für Nuklearmedizin der Universität Würzburg, Josef-Schneider-Strasse 2, 97080, Würzburg, Germany. lassmann@nuklearmedizin.uni-wuerzburg.de.
Summary
New guidelines for paediatric nuclear medicine provide weight-independent effective doses for children using revised dosage cards. This ensures consistent image quality and standardized radiopharmaceutical administration across Europe.
Area of Science:
- Nuclear Medicine
- Paediatric Imaging
- Radiopharmaceutical Dosimetry
Background:
- Recent work by Jacobs et al. proposed tracer-dependent dosage cards for paediatric nuclear medicine.
- Previous EANM dosage cards by Piepsz et al. are being replaced.
Purpose of the Study:
- To introduce a condensed and revised EANM dosage card for paediatric nuclear medicine.
- To standardize radiopharmaceutical administration and ensure image quality in children.
Main Methods:
- Revision and condensation of existing dosage card recommendations.
- Inclusion of minimum activity guidelines for paediatric diagnostic procedures.
Main Results:
- The revised dosage card ensures weight-independent effective doses for children.
- Minimum activity levels guarantee a standard of image quality across Europe.
- Standardization reduces variability in administered activities for children of the same weight.
Conclusions:
- The updated EANM dosage card enhances safety and consistency in paediatric nuclear medicine.
- Implementation of minimum activities ensures reliable diagnostic imaging in children nationwide.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...